Prostatype Genomics: Activities and action plan to increase sales growth
Prostatype Genomics today presents measures to increase sales growth in prioritized European markets. In connection with this, expected turnover for 2022 and changes in the sales organization are presented.During the year, Prostatype Genomics has focused on establishing market presence in priority European markets (Germany, Spain, Italy, Great Britain and Sweden)."We have taken huge steps towards establishing ourselves in our priority markets and today we have extensive interactions with healthcare and decision makers in all these countries. It has taken slightly longer than we initially